KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Research & Development (2016 - 2025)

Pacific Biosciences Of California has reported Research & Development over the past 16 years, most recently at $22.9 million for Q4 2025.

  • Quarterly results put Research & Development at $22.9 million for Q4 2025, down 16.7% from a year ago — trailing twelve months through Dec 2025 was $97.3 million (down 27.88% YoY), and the annual figure for FY2025 was $97.3 million, down 27.88%.
  • Research & Development for Q4 2025 was $22.9 million at Pacific Biosciences Of California, roughly flat from $22.8 million in the prior quarter.
  • Over the last five years, Research & Development for PACB hit a ceiling of $52.9 million in Q1 2022 and a floor of $20.5 million in Q1 2021.
  • Median Research & Development over the past 5 years was $42.6 million (2021), compared with a mean of $36.7 million.
  • Biggest five-year swings in Research & Development: soared 157.63% in 2022 and later tumbled 46.3% in 2024.
  • Pacific Biosciences Of California's Research & Development stood at $42.6 million in 2021, then rose by 0.11% to $42.6 million in 2022, then grew by 4.51% to $44.5 million in 2023, then tumbled by 38.34% to $27.5 million in 2024, then decreased by 16.7% to $22.9 million in 2025.
  • The last three reported values for Research & Development were $22.9 million (Q4 2025), $22.8 million (Q3 2025), and $22.5 million (Q2 2025) per Business Quant data.